After being spun out from GSK in the biggest London IPO in decades, City analyst are looking for more from the emblematic ...
London-based consumer healthcare group Haleon Plc (NYSE:HLN) stock is trading lower on Thursday. Haleon, GSK Plc’s (NYSE:GSK) spun off, reported revenue of 11.23 billion pounds (US$14.19 billion) for ...
CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a 61p ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results